Cyfuse Biomedical K.K. announced today that it has entered into an Business Partnership Agreement with Marubeni Corporation regarding global expansion of a new Bio 3D printer S-PIKE® that Cyfuse has developed and commercialized.

2019.10.23.

Cyfuse Biomedical K.K.(Headquarters:Bunkyo Ward,Tokyo,CEO:Shizuka Akieda,hereinafter, "Cyfuse") announced today that it has entered into an Business Partnership Agreement with Marubeni Corporation (Headquarters:Tokyo,Japan,President:Masumi Kakinoki, hereinafter, "Marubeni")
regarding global expansion of a new Bio 3D printer S-PIKE® that Cyfuse has developed and commercialized.
Cyfuse aim to expand dissemination of platform technology abd accelerate research and development for researchers of regenerative medicine and tissue engineering though the global co-promotion of S-PIKE® with Leading Trading Conglomerate,Marubeni.

For more information

Marubeni Corporation

About S-PIKE®